RYAN BELLAW: Open Payments
NPI 1215065917 · MOUNT PLEASANT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 11 payments from 8 companies in 2025. Trend: 2023 $95 · 2024 $157 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| Novo Nordisk Inc | 1 | $48 |
| Exact Sciences Corporation | 2 | $35 |
| Corcept Therapeutics | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $13 |
Products named: VOQUEZNA, Ozempic, Cologuard Collection Kit, Korlym, CAPLYTA, GEMTESA, XIFAXAN, Auvelity.
Industry payments across TX — which companies pay providers there.
